OVERVIEW

Digital Therapeutics and Pharma Summit is organized by Allan Lloyds and will be held from Sep 22 - 23, 2021 at Vienna, Wien, Austria.

Who Will You Meet:
Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from banking industry involved in:
• Digital Therapeutics
• Digital Healthcare
• Healthcare Solutions
• Digital Devices
• E-health
• Digital Treatment
• Healthcare Solutions
• Digital Partnerships
• Health Partnerships
• IT Digital
• Health Economics
• Health Strategy
• Digital Strategy Innovations
• Integrated CareDigital Technologies
• Measurement Science
• Digital Transformation
• R&D Digital

Description:
In today’s environment, they can see that digital therapeutics (DTx) field represents a new generation of healthcare that uses in many cases innovative, clinically-validated disease management and direct treatment technologies in order to enhance, and in some cases replace, current medical practices and treatments for patients and their better life. There is one question which remaining the same – what are the most promising technologies in the improvement of healthcare? The answer would be easy, digital therapeutics treatments! However, the reality is much more complicated to apply. If medical health solution comes in a digital way, people do not always understand that it could be used not only for monitoring, but also for diagnostics, therapeutic treatments or just for a wellness product application. Let’s reveal what is beyond!

Topics:
Hot topics that will be discussed at this annual
• What are the opportunities and threats of digital therapeutics after COVID-19 time?
• How science + data + technology + evidence works in DTx?
• Let’s discuss the “success” in the digital therapeutics field
• Tools that systematically identify and evaluate RWD sources
• Applying artificial intelligence to promote the well-being of each patient
• How monitoring devices can control the patient’s health?
• Approaches that can be a model for other healthcare systems that are looking for digital innovation
• Developing digital health ecosystems and mainstreaming safe and inclusive services
• Can DTx companies exist with both FDA and Non-FDA regulated therapeutics?

Additional details will be posted as soon as information is available.